Logo

ALDFW

Aldel Financial II Inc.

ALDFW

Aldel Financial II Inc. • NASDAQ
$0.52 ▼ -23.53% (-0.16)
Market Cap $19.13 M
52w High $0.68
52w Low $0.52
Dividend Yield 0%
P/E 0
Volume 46
Outstanding Shares 36.79M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $0 ▼ $0 ▼ 0% $0.082 ▲ $0 ▲
Q2-2025 $0 $105.958K ▲ $2.39M ▲ 0% $0.08 ▲ $-105.958K ▼
Q1-2025 $0 $0 $0 0% $0.075 $0

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $746.386K ▼ $241.577M ▲ $13.364K ▲ $914.24K ▼
Q2-2025 $809.438K ▼ $239.113M ▲ $57 ▼ $1.034M ▼
Q1-2025 $879.298K $236.736M $12.806K $1.14M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $2.451M ▼ $2.508M ▼ $230.596M ▲ $0 ▲ $-63.052K ▲ $2.508M ▼
Q2-2025 $2.749M $3.039M $-4.912M $-232.383M $-194.647K $3.039M

Five-Year Company Overview

Income Statement

Income Statement Aldel Financial II currently has no real operating business, so its income statement is essentially empty. There is no revenue, no core expenses, and no operating profit because the company exists only as a financing vehicle waiting to merge with a private company. Any small reported earnings per share mainly reflect accounting items, not an ongoing business. At this stage, traditional profitability analysis is not meaningful; performance will only become clear after a merger is completed and a real operating company is in place.

Balance Sheet

Balance Sheet The available balance sheet details are minimal, but as a SPAC, Aldel Financial II is mainly a pool of cash raised from investors plus shares and warrants issued at the IPO. Its value today is more about the cash held in trust and the structure of its obligations than about factories, brands, or long-lived assets. Until a deal is announced, the balance sheet is essentially a temporary holding structure rather than a reflection of a functioning business with assets and liabilities tied to operations.

Cash Flow

Cash Flow Cash flows are effectively flat from an operating standpoint, because the company has no products, customers, or day‑to‑day business activity. Most cash movements are related to SPAC mechanics, such as IPO proceeds and the routine costs of staying listed and searching for a target. There is no meaningful free cash flow to evaluate yet; that will only emerge if and when Aldel Financial II completes a merger and begins reporting as an operating company.

Competitive Edge

Competitive Edge In the SPAC world, competitive strength comes from people and relationships rather than products or market share. Aldel Financial II’s edge is its leadership team, which has deep experience in financial services and a prior SPAC that successfully merged with Hagerty. This history may help attract quality targets and negotiate deals. However, the SPAC market is crowded, many sponsors are chasing a limited pool of attractive companies, and timing, deal quality, and investor sentiment around SPACs all represent important uncertainties.

Innovation and R&D

Innovation and R&D Aldel Financial II does not conduct traditional research and development because it has no products of its own. Its “innovation” is more about deal design, target selection, and how it structures a merger to help a private company enter public markets. Any real technological or product innovation that matters to long‑term value will come from the business it eventually acquires, not from Aldel Financial II itself. Until a target is named, there is nothing concrete to assess on the R&D front.

Summary

Aldel Financial II is a classic blank‑check company: no revenue, no operations, and no products today. Its entire story hinges on the management team’s ability to find and close a merger with a strong private business. The leadership has relevant experience and a prior SPAC transaction to point to, which is a positive, but there is still complete uncertainty about the future target, the terms of any deal, and how markets will receive it. For now, the financials are mostly shell structures rather than indicators of business health, and the key variables are execution quality, deal timing, and overall conditions in the SPAC and IPO market.